位置:首页 > 产品库 > 3-Bromopyruvic acid
立即咨询
咨询类型:
     
*姓名:
*电话:
*单位:
Email:
*留言内容:
请详细说明您的需求。
*验证码:
 
3-Bromopyruvic acid
本产品不向个人销售,仅用作科学研究,不用于任何人体实验及非科研性质的动物实验。
3-Bromopyruvic acid图片
CAS NO:1113-59-3

3-溴丙酮酸
Bromopyruvic acid
Hexokinase II Inhibitor II, 3-BP
3-Bromopyruvic acid 是己糖激酶 II (hexokinase II,HXK II) 抑制剂,是一种有效的针对肝癌细胞的抗肿瘤剂。
生物活性

3-Bromopyruvate (Bromopyruvic acid) is an analogue of pyruvate and a potenthexokinase(HK)-IIinhibitor with high tumor selectivity. 3-Bromopyruvate inhibits cell growth and inducesapoptosisthrough interfering with glycolysis. 3-Bromopyruvate inducesautophagyby stimulating ROS formation in breastcancercells. Antimicrobial activities[1][2][3].

体外研究
(In Vitro)

3-Bromopyruvate enhances TRAIL-induced apoptosis in breast cancer cells[2].
3-Bromopyruvate (Bromopyruvic acid), a hexokinase II inhibitor, can induce apoptosis in hepatocellular carcinoma cells by inducing endoplasmic reticulum (ER) stress[2].
3-Bromopyruvate inhibits ATP generation and upregulates the expression of DR5. 3-Bromopyruvate upregulates CHOP, GRP78 and the phosphorylation of AMPK and augments TRAIL-induced Bax and caspase-3 levels[2].

Cell Viability Assay[2]

Cell Line:MCF-7 and MDA-MB-231 cells
Concentration:40, 80, 160 or 320 μM
Incubation Time:24 hours
Result:3-Bromopyruvate (80 and 160 μmol/l) and TRAIL (400 ng/ml) significantly inhibited cell viability.
体内研究
(In Vivo)

3-Bromopyruvate (8 mg/kg; i.p.; every 4 days for 28 days) shows a synergistic antitumor effect in MCF-7 cell xenografts in nude mice[2].

Animal Model:Female nude mice (BALB/c; 4-5-weeks old and 18-20 g)[2]
Dosage:8 mg/kg
Administration:I.p.; every 4 days for 28 days
Result:Showed antitumor efficacy in tumor xenografts.
分子量

166.96

性状

Solid

Formula

C3H3BrO3

CAS 号

1113-59-3

中文名称

3-溴丙酮酸;溴丙酮酸;3-溴庚酸;3-溴代丙酮酸

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

4°C, sealed storage, away from moisture

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture)

溶解性数据
In Vitro: 

H2O : 250 mg/mL(1497.36 mM;Need ultrasonic)

配制储备液
浓度溶剂体积质量1 mg5 mg10 mg
1 mM5.9895 mL29.9473 mL59.8946 mL
5 mM1.1979 mL5.9895 mL11.9789 mL
10 mM0.5989 mL2.9947 mL5.9895 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80℃, 6 months; -20℃, 1 month (sealed storage, away from moisture)。-80℃ 储存时,请在 6 个月内使用,-20℃ 储存时,请在 1 个月内使用。

In Vivo:

请根据您的实验动物和给药方式选择适当的溶解方案。以下溶解方案都请先按照In Vitro方式配制澄清的储备液,再依次添加助溶剂:

——为保证实验结果的可靠性,澄清的储备液可以根据储存条件,适当保存;体内实验的工作液,建议您现用现配,当天使用; 以下溶剂前显示的百
分比是指该溶剂在您配制终溶液中的体积占比;如在配制过程中出现沉淀、析出现象,可以通过加热和/或超声的方式助溶

  • 1.

    请依序添加每种溶剂: PBS

    Solubility: 100 mg/mL (598.95 mM); Clear solution; Need ultrasonic

*以上所有助溶剂都可在本网站选购。
 
 
维奥蛋白资源库 - 中文蛋白资源 CopyRight © 2010-2024